STOCK MARKET

Novo Nordisk Shares Plunge After Wegovy Maker Cuts Full-Year Guidance Published on July 29, 2025 | Pharmaceuticals & Markets Novo Nordisk (NVO) , the Danish pharmaceutical giant behind blockbuster weight-loss drug **Wegovy**, saw its shares tumble **over 8%** in early trading after the company slashed its full-year sales and profit guidance, citing supply constraints and regulatory delays. What Happened? The company now expects: **Sales growth** of 14-17% (down from 19-27%) **Operating profit growth** of 16-20% (vs. previous 22-30%) "While demand for our obesity and diabetes treatments remains exceptionally strong, we are facing temporary capacity limitations," — Novo Nordisk CEO Lars Fruergaard Jørgensen in a statement. Key Reasons Behind the Guidance Cut Production bottlenecks  for Wegovy and Ozempic FDA delays  in approving expanded manufacturing facilities Increased competition  from Eli Lilly's Zepbound Pricing pressures  in key markets like the U.S. Market ...

  Samsung Secures $1.65 Billion Deal to Manufacture Tesla's Next-Gen AI Chips Published on July 28, 2025 | Technology & Business In a significant development for the semiconductor and electric vehicle industries, Samsung Electronics has landed a $1.65 billion contract to manufacture Tesla's advanced AI chips, as confirmed by Elon Musk himself. The Landmark Agreement The deal, announced earlier this week, will see Samsung produce Tesla's sixth-generation AI chips (AI6) at its state-of-the-art fabrication plants. This partnership marks a major shift in Tesla's supply chain strategy and strengthens Samsung's position in the automotive semiconductor market. "We're excited to work with Samsung on our next-generation AI hardware," Musk stated. "Their manufacturing expertise combined with our AI architecture will enable unprecedented performance in our vehicles and robotics systems." Why This Partnership Matters The collaboration brings together...